Community/Retail

Sanofi announced today that the FDA has approved its 24-hour formulation of levocetirizine dihydrochloride (Xyzal Allergy 24HR) for the over-the-counter (OTC) treatment of symptoms associated with seasonal and year-round allergies.

Rosacea is a chronic skin condition characterized by transient or persistent erythema of the central face including inflammatory papules or pustules, telangiectasia, or hyperplasia of the connective tissue.1 At least 14 million people in the United States have rosacea, and the prevalence may be as high as 5%.1,2 This disease is most common in women (especially during menopause), people with fair skin, and in adults between the ages of 30 and 60.2

The Meijer Simply Give program set a record in 2016 with $7.8 million for food pantries throughout the Midwest, bringing the program’s overall donation to more than $28 million since its inception in 2008.